Oct 14, 2022

Valent BioSciences now sells biostimulants to U.S. customers

Valent BioSciences LLC established a new operating unit to sell direct in February, which became fully operational on Oct. 1.

The new unit enables the organization to serve the entire U.S market. The transition marks a major change in the go-to-market strategy for Valent BioSciences, selling directly to U.S. channel partners.
The new biostimulant business team and salesforce are focused on discovering, developing and commercializing arbuscular mycorrhizal fungi (AMF) products, among other biostimulants, to sustainably maximize retailer and grower profitability.

“As both market volatility and the global population increase, biostimulants can be used to sustainably improve crop performance and ROI,” Salman Mir, executive vice president and chief operating officer, said in a news release. “Biostimulant products, including our AMF technologies, also support the mission of our parent company, Sumitomo Chemical Co. Ltd., for achieving carbon neutrality by 2050, as well as its global goal of attaining carbon neutrality for society as a whole.”

The core Valent BioSciences biostimulant products are being marketed under the Symvado and Proliant brand names. The company will be employing a variety of newly created tools and digital assets to support commercialization of these brands in the U.S. market, according to the release.

“We recognize that biostimulants can be challenging products for customers to successfully utilize, so we are adapting our strategy to best address customer needs and drive value for all parties,” Dave Schumacher, vice president of commercial operations for Valent BioSciences, said in the release.
The new biostimulants business at Valent BioSciences includes numerous technical experts who are available to help retailers and growers navigate this complex market segment.

“We have more than 60 years of broad biorational crop enhancement expertise, and this launch incorporates the next generation of tools to help our customers succeed,” Mir said in the release. “We are in an excellent position to lead the biostimulants industry as it transitions to science-driven biostimulant products that positively impact the bottom line.”

For more information about Valent BioSciences, visit valentbiosciences.com.